Maximising access to COVID-19 vaccination in pregnancy

NHS England has written to ask maternity service leads to co-ordinate with Vaccination Programme leads so that every woman attending a maternity service has easy, timely access to vaccine confidence conversations and co-located vaccination offers.

Read the letter from 25 January 2022 here, and also the RCOG / RCM updated Information sheet and decision aid it links to: (Updated Monday 20 December 2021)

DHSC vision for the Women’s Health Strategy for England

Image Source: DHSC

In March this year, the government launched a call for evidence to inform the development of the first Women’s Health Strategy for England.

Analysis of the call for evidence consultation response has informed the development of this document, which is published alongside the consultation response.

This document sets out the government’s Vision for the Women’s Health Strategy for England. 

RCOG Coronavirus (COVID-19) Infection in Pregnancy Information for healthcare professionals Version 14.3

The latest version of RCOG’s guidance was made available on 11 January 2022, previously having been updated in December 2021.

v14.2 (December 2021) Minor updates included:

• Quick reference summary: replaced by flowchart
• Section 2: Minor updates of vaccination safety data
• Section 6: Clarification of Ronapreve dose to 2.4g, restoration of dexamethasone dose to 12mg intramuscular x2 (24 hours apart), advice not to use Molupiravir outside a trial settings and on neonatal BCG after maternal administration of Tocolizumab.
• Section 7: Update of postnatal neonatal guidance in line with BAPM
• Addition of appendix IV: Example of a telephone triage tool for symptomatic women with suspected or confirmed COVID-19

Also included is a Treatment of COVID-19 in pregnant patients one page sheet

Version 14.3 January 2022 minor updates include:

• Section 2: Minor updates on omicron vaccine efficacy.
• Section 6: Recognition that monoclonal antibody advice is
changing rapidly, with external links for clarification. Clarification
of recommended steroid preparations, with addition of
methylprednisolone if preferred.
• Section 7: Aligning with BAPM isolation advice.

View the updated guidance here